1. Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia
- Author
-
Giuseppe Pietrantuono, Giovanni D'Arena, Roberto Guariglia, F. Di Raimondo, Massimo Offidani, Paola Omedè, Attilio Olivieri, Nicola Cascavilla, Tommaso Caravita, Roberto Mina, Pellegrino Musto, Katia Todoerti, Maide Cavalli, Nunzio Filardi, Mario Boccadoro, Fortunato Morabito, Francesco Nobile, Sara Bringhen, Antonio Palumbo, Luca Agnelli, Maria Carmen Martorelli, Oreste Villani, Antonino Neri, Vittorio Simeon, G. Mansueto, A. Falcone, Giulia Benevolo, Rosa Lerose, M.T. Petrucci, Anna Levi, Musto, P, Simeon, V, Martorelli, M C, Petrucci, M T, Cascavilla, N, Di Raimondo, F, Caravita, T, Morabito, F, Offidani, M, Olivieri, A, Benevolo, G, Mina, R, Guariglia, R, D'Arena, G, Mansueto, G, Filardi, N, Nobile, F, Levi, A, Falcone, A, Cavalli, M, Pietrantuono, G, Villani, O, Bringhen, S, Omedè, P, Lerose, R, Agnelli, L, Todoerti, K, Neri, A, Boccadoro, M, and Palumbo, A
- Subjects
Oncology ,Adult ,Male ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Newly diagnosed ,Dexamethasone ,Leukemia, Plasma Cell ,Internal medicine ,medicine ,Humans ,Lenalidomide ,Aged ,Plasma cell leukemia ,Aged, 80 and over ,Chemotherapy ,business.industry ,Low dose ,Hematology ,Middle Aged ,medicine.disease ,Surgery ,Thalidomide ,Female ,business ,medicine.drug - Published
- 2013